Lukas Biomedical Inc. (TPEX:6814)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.20
+0.70 (2.64%)
At close: Mar 10, 2026
8.37%
Market Cap 1.11B
Revenue (ttm) 180.32M
Net Income (ttm) -96.22M
Shares Out 41.87M
EPS (ttm) -2.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 39,011
Average Volume 14,830
Open 26.50
Previous Close 26.50
Day's Range 25.70 - 27.20
52-Week Range 16.60 - 32.50
Beta 0.14
RSI 25.56
Earnings Date Apr 27, 2026

About Lukas Biomedical

Lukas Biomedical Inc. engages in the wholesale and retail of cosmetics in Taiwan. The company operates through E-Commerce Department, Medical Management Business, Cell Products Department, and Pharmaceutical Market Development Department segments. It also researches and develops immune cell medical technology for regenerative medicine and adjuvant treatment; engages in clinical trials; distributes immune cell therapy culture technology; and leases building equipment. In addition, the company involved in the new immune cell research and developm... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 96
Stock Exchange Taipei Exchange
Ticker Symbol 6814
Full Company Profile

Financial Performance

In 2024, Lukas Biomedical's revenue was 189.83 million, a decrease of -18.12% compared to the previous year's 231.83 million. Losses were -94.38 million, 99.3% more than in 2023.

Financial Statements

News

There is no news available yet.